摘要
再狭窄 (Restenosis,RS)是随着经皮腔内冠状动脉成形术 (PTCA)等介入治疗技术用于治疗冠心病而带来的一个新的临床问题 ,严重影响了PTCA这一有效治疗方法的远期疗效。为认识了解再狭窄的发生与发展 ,达到有效防治的目的 ,过去十余年各国医学界 ,特别是心血管病学界进行了大量的研究 ,并从过程、发生机制到临床对策都取得了显著的成果。在现代科技革命条件下 。
Restenosis (RS) is a new clinical problem caused by percutaneous transluminal coronary angioplasty (PTCA) being used to the treatment of coronary heart disease (CHD) and it badly affects the late result of PTCA on CHD.In order to study the occurrence and development of RS,to achieve the goal of prevention and cure,medical workers have put much attention to this problem in last decade and got obvious positive results about its process,mechanism and clinical countermeasure.Under the condition of scientific and technical revolution,this study process obviously possess the characteristic of modern scientific cognition.
出处
《医学与哲学》
2000年第1期23-26,共4页
Medicine and Philosophy
